Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panitumumab in metastatic/recurrent SCCHN
NCT00446446Phase 2Completed
- Sponsor
- Amgen
- Start
- Oct 2007
- Primary completion
- Dec 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
01
Overview
A Phase 2 trial of panitumumab in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Amgen. Started Oct 2007; status: completed.
02
Drugs
panitumumab
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00446446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00446446.